European Association for Vision and Eye Research

EVER 2018 Congress

Upcoming deadline

March 15

SIS/Course summary
submission deadline

More important dates

SIS and course summary submission

Speakers in SIS and courses at EVER 2018 need to submit their summary.

Deadline March 15, 2018 at 23:59 PM - CET.

For SIS summary submission click here.

For COURSE summary submission click here.

Instructions have been sent to SIS and course speakers by e-mail.

For questions, please contact ever@ever.be

EVER President 2018

Alain BRON

read here his words of welcome

2018 EVER membership now available

Be part of our community and join EVER that will support you in your career development all year long.

Membership fee & member benefits

Login and pay your membership 2018 here.

Access the official journal here:

ActaOphthalmologica

AOS EVER 2017 supplement (AOS 95:S259) - Published online
Impact Factor: 3.157

The supplement is also available through Wiley Online Library (WOL).

Sponsor opportunities

We invite all sponsors to be part of EVER 2018!

The detailed brochure with sponsorship opportunities is available now.

New at EVER 2018

Innovations & Novel Products in Ophthalmology (INPO)

Session scheduled on Friday Oct. 5 from 12:30-13:30

Principal investigators present their academic projects with commercialization opportunities.

Interested?  Click here.

Application deadline March 15!

EVERÆ’ Fellowships

Call for fellowships 2019 will open on June 1 on the
EVER Foundation website.

14th ISOPT Clinical

Tel-Aviv, Israel

March 1-3, 2018

Ophthalmology Tour 2018 North India

Ophthalmology in India
18 February - 2 March 2018
Prof. Harminder Dua, EVER COS member, will be the tour leader.

More information can be found here.



 
This peer-reviewed, online-only, open access journal is dedicated exclusively to publishing original case reports across the entire spectrum of ophthalmology.

ARVO 2018

Honolulu, April 29 - May 3, 2018

Composition of the Board

Who is who in the EVER board?
See Board composition
here.